Want to see AU:PKP full AI Analyst Report?
Top Page
Althea Group Holdings Ltd.
(Sydney:PKP)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.01
â–²(40.00% Upside)
Action:Reiterated
Date:06/20/26
The score is primarily held back by weak financial performance (sharp revenue contraction, ongoing losses and cash burn, and negative equity). Technicals also remain bearish with the stock trading below key moving averages and very low RSI, while valuation offers limited support due to negative earnings and no dividend yield.
Positive Factors
Gross Margin Resilience
A positive and improving gross margin (~48%) indicates the company retains healthy product-level economics despite top-line weakness. That margin base supports operating leverage if revenue stabilises, enabling a pathway to profitability without requiring structural pricing changes.
Negative Factors
Revenue Contraction
A ~38% revenue decline is a structurally negative signal: it reduces scale, weakens pricing and supplier leverage, and undermines the company’s ability to spread fixed costs. Sustained top-line shrinkage hampers recovery of operating margins and cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Gross Margin Resilience
A positive and improving gross margin (~48%) indicates the company retains healthy product-level economics despite top-line weakness. That margin base supports operating leverage if revenue stabilises, enabling a pathway to profitability without requiring structural pricing changes.
Read all positive factors
Althea Group Holdings Ltd. (PKP) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$20.68M
Dividend YieldN/A
Average Volume (3M)2.39M
Price to Earnings (P/E)―
Beta (1Y)0.39
Revenue Growth-19.29%
EPS Growth62.42%
CountryAU
EmployeesN/A
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,334,388,900
10 Day Avg. Volume1,968,059
30 Day Avg. Volume2,389,843
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Althea Group Holdings Ltd. Business Overview & Revenue Model
Company Description
Based in Melbourne, Australia, and founded in 2016, Peak Processing Limited, alongside its subsidiaries, is engaged in the manufacturing, distribution, and sale of recreational cannabis products throughout Canada and the United States. Its extensi...
How the Company Makes Money
null...
Althea Group Holdings Ltd. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
14
Very Negative
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Althea Group Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
53 Neutral | AU$8.30M | 0.30 | 64.70% | ― | -24.22% | ― | |
53 Neutral | AU$54.65M | -14.35 | -1.67% | ― | 15.21% | -141.82% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$17.89M | -4.03 | -9.80% | 7.41% | 5.74% | -222.22% | |
50 Neutral | AU$3.51M | -0.79 | -50.35% | ― | -4.87% | -9.78% | |
50 Neutral | AU$18.96M | -7.19 | -13.81% | 6.27% | 5.93% | 66.32% | |
42 Neutral | AU$20.68M | -5.07 | 4388.00% | ― | -19.29% | 62.42% |
* Healthcare Sector Average
AU:PKP
Althea Group Holdings Ltd.
0.02
>-0.01
-28.57%
AU:EXL
Elixinol Wellness
0.02
>-0.01
-11.76%
AU:CAN
Cann Group
0.01
>-0.01
-16.67%
AU:LGP
Little Green Pharma Ltd.
0.07
-0.07
-50.00%
AU:IDT
IDT Australia Limited
0.05
-0.02
-24.62%
AU:VIT
Cronos Australia Ltd.
0.02
-0.04
-65.15%
Althea Group Holdings Ltd. Corporate Events
Peak Processing Director Boosts Equity Stake Through Share-Based Remuneration
Jul 26, 2026
Peak Processing Limited has reported a change in director Barry Katzman’s indirect interest, with his associated entity 2756278 Ontario Inc. receiving 5,650,000 new ordinary shares. These shares were issued in lieu of $158,200 in cash remune...
Peak Processing Issues Shares to Related Party in Lieu of Cash Pay
Jul 26, 2026
Peak Processing Limited has issued 5,650,000 fully paid ordinary shares at a deemed price of $0.028 per share to a related party in lieu of cash remuneration, following shareholder approval at its 25 June 2026 general meeting. The shares were issu...
Peak Processing Seeks ASX Quotation for 5.65 Million New Shares
Jul 24, 2026
Peak Processing Limited has applied for quotation on the ASX of 5,650,000 ordinary fully paid shares under the code PKP. The new securities, issued on July 24, 2026, form part of a previously announced transaction and will expand the company’...
Peak Processing director boosts stake via placement and fee shares
Jul 1, 2026
Peak Processing Limited has disclosed a change in the interests of director Manik Pujara, whose holdings are held indirectly through Trinetra Holdings Pty Ltd. Following recent corporate actions approved at a general meeting, his stake now compris...
Peak Processing converts loan notes to equity and issues director shares
Jun 30, 2026
Peak Processing Limited has issued a total of 168,133,316 fully paid ordinary shares following shareholder approvals at a recent general meeting. The bulk of the new equity arises from the conversion of loan notes held by professional and sophisti...
Peak Processing Issues 25 Million Unquoted Long Dated Options
Jun 30, 2026
Peak Processing Limited has notified the market of a new issue of 25,000,000 unquoted options, each expiring on 13 February 2029 with an exercise price of $0.025. The options form a new class of securities that will not be quoted on the ASX and ar...
Peak Processing Seeks ASX Quotation for 4 Million New Shares
Jun 30, 2026
Peak Processing Ltd. has applied to the ASX for quotation of 4,000,000 ordinary fully paid shares, expanding its listed securities base under the issuer code PKP. The new shares, issued on June 29, 2026 and disclosed via an Appendix 2A filing, sig...
Peak Processing Seeks ASX Quotation for 4 Million New Shares
Jun 30, 2026
Peak Processing Limited, trading on the ASX as PKP, is an Australian public company that issues ordinary fully paid shares, positioning itself within the listed equities market. The release does not specify its operating sector or product focus, l...
Peak Processing Issues 25 Million Unquoted Options Expiring in 2028
Jun 30, 2026
Peak Processing Limited has notified the market of a new issue of unquoted equity securities in the form of options. The company is expanding its equity-linked capital structure, reflecting ongoing use of options as a tool for financing or incenti...
Peak Processing Seeks ASX Quotation for 160 Million New Shares
Jun 30, 2026
Peak Processing Limited has applied for quotation of 160,133,316 ordinary fully paid shares on the ASX, with the securities issued on June 29, 2026. The application, lodged as a new announcement under Appendix 2A, formalizes the listing of these p...
Peak Processing Secures Exclusive Fryday Kush THC Beverage Deal in 13 U.S. States
Jun 29, 2026
Peak Processing Limited’s U.S. arm, Peak USA Inc., has signed a three-year exclusive manufacturing agreement with BTAB Solutions to produce THC beverages under the Fryday Kush brand across 13 American states. The deal extends a proven Canadi...
Peak Processing shareholders back most resolutions, reject establishment-fee share issue
Jun 25, 2026
Peak Processing Limited reported the results of its general meeting held on 25 June 2026, where shareholders voted on a series of resolutions by poll. All but one resolution received the requisite majority support, reflecting broad investor backin...
Peak Processing Extends Earnings Turnaround as Production Beats Guidance
Jun 16, 2026
Peak Processing has extended its earnings turnaround, delivering three consecutive months of positive EBITDA at the group level in March, April, and May 2026, alongside record May revenue of A$1.71 million. The company expects fourth-quarter FY26 ...
Peak Processing Plans Placement of Up to 5.65 Million New Shares
May 22, 2026
Peak Processing Limited has notified the ASX of a proposed issue of up to 5,650,000 ordinary fully paid shares under a placement or similar capital-raising structure. The new securities, expected to be issued on 26 June 2026, form part of the comp...
Peak Processing plans major share and option issue on ASX
May 4, 2026
Peak Processing Limited, listed on the ASX under the code PKP, is an Australian public company engaged in capital market activities through the issuance of ordinary equity and options. The specific industry focus and operating segments of the busi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.